KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Debt: 2009-2024

Historic Total Debt for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $2.2 billion.

  • Charles River Laboratories International's Total Debt fell 6.07% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 6.07%. This contributed to the annual value of $2.2 billion for FY2024, which is 15.37% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Total Debt of $2.2 billion as of FY2024, which was down 15.37% from $2.6 billion recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Total Debt peaked at $2.7 billion during FY2022, and registered a low of $2.0 billion during FY2020.
  • In the last 3 years, Charles River Laboratories International's Total Debt had a median value of $2.6 billion in 2023 and averaged $2.5 billion.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 34.68% in 2021, then dropped by 15.37% in 2024.
  • Charles River Laboratories International's Total Debt (Yearly) stood at $2.0 billion in 2020, then spiked by 34.68% to $2.7 billion in 2021, then rose by 1.54% to $2.7 billion in 2022, then declined by 2.23% to $2.6 billion in 2023, then decreased by 15.37% to $2.2 billion in 2024.